Antihypertensive effects of Artemisia scoparia waldst in spontaneously hypertensive rats and identification of angiotensin I converting enzyme inhibitors

Molecules

Volumn 20, Issue 11, 2015, Pages 19789-19804

  Cho, Jeong Yong ^a   Park, Kyung Hee ^a   Hwang, Do Young ^a   Chanmuang, Saoraya ^a   Jaiswal, Lily ^a   Park, Yang Kyun ^a   Park, Sun Young ^a   Kim, So Young ^b   Kim, Haeng Ran ^b   Moon, Jae Hak ^c   Ham, Kyung Sik ^a  

^a Mokpo National University   (South Korea)

^b Division of Functional Food and Nutrition   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

ACE inhibitor; Artemisia scoparia; Blood pressure; Halophyte; Phenolics

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLANT EXTRACT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN A;

ANIMAL; ARTEMISIA; BLOOD PRESSURE; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; KIDNEY; LIPID PEROXIDATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTEMISIA; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; LIPID PEROXIDATION; MUSCLE, SKELETAL; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, INBRED SHR; RHOA GTP-BINDING PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84949971834     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201119657     Document Type: Article

References (66)

1. Drazner, M.H. The progression of hypertensive heart disease. Circulation 2011, 123, 327-334. [CrossRef] [PubMed]
2. Player, M.S.; Peterson, L.E. Anxiety disorders, hypertension, and cardiovascular risk: A review. Int. J. Psychiatry Med. 2011, 41, 365-377. [CrossRef] [PubMed]
3. Boeing, H.; Bechthold, A.; Bub, A.; Ellinger, S.; Haller, D.; Kroke, A.; Leschik-Bonner, E.; Muller, M.; Oberritter, H.; Achulze, M.; et al. Critical review: Vegetables and fruit in the prevention of chronic diseases. Eur. J. Nutr. 2012, 51, 637-663. [CrossRef] [PubMed]
4. Wang, L.; Manson, J.E.; Gaziano, J.M.; Buring, J.E.; Sesso, H.D. Fruit and vegetable intake and the risk of hypertension in middle-aged and older women. Am. J. Hypertens. 2012, 25, 180-189. [CrossRef] [PubMed]
5. McCall, D.O.; McGartland, C.P.; McKinley, M.C.; Patterson, C.C.; Sharpe, P.; McCance, D.R.; Young, I.S.; Woodsice, J.V. Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation 2009, 119, 2153-2160. [CrossRef] [PubMed]
6. Ksouri, R.; Ksouri, W.M.; Jallali, I.; Debez, A.; Magne, C.; Hiroko, I.; Abdelly, C. Medicinal halophytes: Potent source of health promoting biomolecules with medical, nutraceutical and food applications. Crit. Rev. Biotechnol. 2012, 32, 289-326. [CrossRef] [PubMed]
7. Rhee, M.H.; Park, H.J.; Cho, J.Y. Salicornia herbacea: Botanical, chemical and pharmacological review of halophyte marsh plant. J. Med. Plants Res. 2009, 3, 548-555.
8. Priyashree, S.; Pattanayak, S.P. A review on Cressa cretica Linn.: A halophytic plant. Pharmacogn. Rev. 2010, 4, 161-166. [CrossRef] [PubMed]
9. Oueslati, S.; Ksouri, R.; Falleh, H.; Pichette, A.; Abdelly, C.; Legualt, J. Phenolic content, antioxidant, anti-inflammatory and anticancer activities of the edible halophyte Suaeda fruticosa Forssk. Food Chem. 2012, 132, 943-947. [CrossRef]
10. Joseph, D.; Chakraborty, K.; Subin, C.S.; Vijayan, K.K. Halophytes of Chenopodiaceae and Aizoaceae from south-east coast of India as potential sources of essential nutrients and antioxidants. J. Food Nutr. Res. 2013, 1, 97-107.
11. Yang, C.; Zheng, S.; Huang, H.; Liu, Z.; Zheng, W.; Liu, B.; Shi, D. Comparison of osmatic adjustment and ion balance strategies in nineteen alkali-tolerant halophyte species during adaptation to salt-alkalinized habitats in northeast China. Aust. J. Crop Sci. 2012, 6, 141-148.
12. Kim, J.Y.; Cho, J.Y.; Ma, Y.K.; Park, K.Y.; Lee, S.H.; Ham, K.S.; Lee, H.J.; Park, K.H.; Moon, J.H. Dicaffeoylquinic acid derivatives and flavonoid glucosides from glasswort (Salicornia herbacea L.) and their antioxidative activity. Food Chem. 2011, 125, 55-62. [CrossRef]
13. Glenn, E.P.; Brown, J.J. Salt tolerance and crop potential of halophytes. Crit. Rev. Plant Sci. 1999, 18, 227-255. [CrossRef]
14. Parida, A.K.; Das, A.B. Salt tolerance and salinity effects on plants. Ecotoxicol. Environ. Saf. 2005, 60, 324-349. [CrossRef] [PubMed]
15. Cho, J.Y.; Yang, X.; Lily, J.; Feng, L.; Ham, K.S. Screening on chemical constituent and biological activities of various halophytes. Food Sci. Biotechnol. 2015. to be submitted.
16. Singh, H.P.; Kaur, S.; Mittal, S.; Batish, D.R.; Kohli, R.K. In vitro screening of essential oil from young and mature leaves of Artemisia scoparia compared to its major constituents for free radical scavenging activity. Food Chem. Toxicol. 2010, 48, 1040-1044. [CrossRef] [PubMed]
17. Cha, J.D.; Jeong, M.R.; Jeong, S.I.; Moon, S.E.; Kim, J.Y.; Kil, B.S.; Song, Y.H. Chemical composition and antimicrobial activity of the essential oils of Artemisia scoparia and A. capillaris. Planta Med. 2005, 71, 186-190. [CrossRef] [PubMed]
18. Lee, Y.M.; Hsiao, G.; Chang, J.W.; Sheu, J.R.; Yen, M.H. Scoparone inhibits tissue factor expression in lipopolysaccharide-activated human umbilical vein endothelial cells. Biomed. Sci. 2003, 10, 518-525. [CrossRef]
19. Pan, S.L.; Huang, Y.W.; Guh, J.H.; Chang, Y.L.; Peng, C.Y.; Teng, C.M. Esculetin inhibits ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats. Biochem. Pharmacol. 2003, 65, 1897-1905. [CrossRef]
20. Chen, Y.L.; Huang, H.C.; Weng, Y.I.; Yu, Y.J.; Lee, Y.T. Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidemic diabetic rabbit. Cardiavasc. Res. 1994, 28, 1679-1685. [CrossRef]
21. Wang, Z.Q.; Zhang, X.H.; Yu, Y.; Tipton, R.C.; Raskin, I.; Ribnicky, D.; Johnson, W.; Cefalu, W.T. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism 2013, 62, 1239-1249. [CrossRef] [PubMed]
22. Yahagi, T.; Yakura, N.; Matsuzaki, K.; Kitanaka, S. Inhibitory effect of chemical constituents from Artemisia scoparia Waldst. et Kit. on triglyceride accumulation in 3T3-L1 cells and nitric oxide production in Raw 264.7 cells. J. Nat. Med. 2014, 68, 414-420. [CrossRef] [PubMed]
23. Iciek, M.; Kwiecień, I.; Wlodek, L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ. Mol. Mutagen. 2009, 50, 247-265. [CrossRef] [PubMed]
24. Shouk, R.; Abdou, A.; Shetty, K.; Sarkar, D.; Eid, A.H. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutr. Res. 2014, 34, 106-115. [CrossRef] [PubMed]
25. Bayan, L.; Koulivand, P.H.; Gorji, A. Garlic: A review of potential therapeutic effects. Avicenna J. Phytomed. 2014, 4, 414-420.
26. Ku, D.D.; Abdel-Razek, T.T.; Dai, J.; Kim-Park, S.; Fallon, M.B.; Abrams, G.A. Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries. Clin. Exp. Pharmacol. Physiol. 2002, 29, 84-91. [CrossRef] [PubMed]
27. Benavides, G.; Squadrito, G.; Mills, R.W.; Patel, H.D.; Isbell, T.S.; Patel, R.P.; Doeller, J.E.; Darley-Usmar, V.M.; Kraus, D.W. Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. USA 2013, 204, 17977-17982. [CrossRef] [PubMed]
28. Ried, K.; Frank, O.R.; Stocks, N.P.; Sullivan, T. Effect of garlic on blood pressure: A systematic review and meta-analysis. BMC Cardiovasc. Disord. 2008, 8. [CrossRef] [PubMed]
29. Dornas, W.A.; Silva, M.E. Animal models for the study of arterial hypertension. J. Biosci. 2011, 36, 731-737. [CrossRef] [PubMed]
30. Ryu, W.S.; Kim, S.W.; Kim, C.J. Overview of the renin-angiotensin system. Korean Circ. J. 2007, 37, 91-96. [CrossRef]
31. Sridevi, P.; Prashanth, K.S.; Bhagavan Raju, M. Angiotensin converting enzyme: A target for antihypertensive drugs. Int. J. Res. Pharm. Biomed. Sci. 2011, 2, 63-72.
32. Kim, S.; Iwao, H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 2011, 52, 12-30.
33. Benigni, A.; Cassis, P.; Remuzzi, G. Angiotensin II revisited: New roles in inflammation, immunology and aging. EMBO Mol. Med. 2010, 2, 247-257. [CrossRef] [PubMed]
34. Hermann, M.; Flammer, A.; Lüuscher, T.F. Nitric oxide in hypertension. J. Clin. Hypertens. 2006, 8 (Suppl. 4), 17-29. [CrossRef]
35. Facemire, C.S.; Nixon, A.B.; Griffiths, R.; Hurwits, H.; Coffman, T.M. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 2009, 54, 652-658. [CrossRef] [PubMed]
36. Francis, S.H.; Busch, J.L.; Corbin, J.D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 2010, 62, 525-563. [CrossRef] [PubMed]
37. Duong-Quy, S.; Bei, Y.; Liu, Z.; Dinh-Xuan, A.T. Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol. Ther. 2013, 137, 352-364. [CrossRef] [PubMed]
38. Pupilli, C.; Lasagni, L.; Romagnai, P.; Bellini, F.; Mannelli, M.; Misciglia, N.; Mavila, C.; Vellei, U.; Villari, D.; Serio, M. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J. Am. Soc. Nephrol. 1999, 10, 245-255. [PubMed]
39. Bregeon, J.; Loirand, G.; Pacaud, P.; Rolli-Derkinderen, M. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2009, 297, C1062-C1070. [CrossRef] [PubMed]
40. Knox, A.J.; Corbertt, L.; Stocks, J.; Holiand, E.; Zhu, Y.M.; Pang, L. Human airway smooth muscle cells secrete vascular endothelial growth factor: Up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J. 2001, 15, 2480-2488. [CrossRef] [PubMed]
41. Schäfer, S.C.; Pellegrin, M.; Wyss, C.; Abert, J.F.; Nussberger, J.; Hayoz, D.; Lehr, H.A; Mazzolai, L. Intravital microscopy reveals endothelial dysfunction in resistance arterioles in angiotensin II-induced hypertension. Hypertens. Res. 2012, 35, 855-861. [CrossRef] [PubMed]
42. Touyz, R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance? Hypertension 2004, 44, 248-252. [CrossRef] [PubMed]
43. Adibhatla, R.M.; Hatcher, J.F. Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2010, 12, 125-169. [CrossRef] [PubMed]
44. Traverso, N.; Menini, S.; Maineri, E.P.; Patriarca, S.; Odetti, P.; Cottalasso, D.; Marinari, U.M.; Pronzato, M.A. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59, 890-895. [CrossRef]
45. Vaziri, N.D. Causal link between oxidative stress, inflammation, and hypertension. Iran J. Kidney Dis. 2008, 2, 1-10. [PubMed]
46. Ide, N.; Lau, B.H. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation. J. Nutr. 2001, 131, 1020S-1026S. [PubMed]
47. Fu, M.; Zhou, J.; Sun, A.; Zhang, S.; Zhang, C.; Zou, Y.; Fu, M.; Ge, J. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction-A meta analysis of 7 prospective clinical studies. Int. J. Cardiol. 2012, 155, 33-38. [CrossRef] [PubMed]
48. Zuanetti, G.; Latini, R.; Maggioni, P.; Franzosi, M.; Santoro, L.; Tognoni, G. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infraction. Circulation 1997, 96, 4239-4245. [CrossRef] [PubMed]
49. Amann, B.; Tinzmann, R.; Angelkort, B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 2003, 26, 2421-2425. [CrossRef] [PubMed]
50. Sala, A.; Recio, M.C.; Giner, R.M.M.; Máñez, S.; Ríos, J.L. New acetophenone glucosides isolated from extracts of Helichrysum italicum with antiinflammatory activity. J. Nat. Prod. 2001, 64, 1360-1362. [CrossRef] [PubMed]
51. Banday, J.A.; Mir, F.A.; Farooq, S.; Qurishi, M.A.; Koul, S.; Razdan, T.K. Salicylic acid and methyl gallate from the roots of Conyza canedensis. Int. J. Chem. Anal. Sci. 2012, 3, 1305-1308.
52. Chung, J.H.; Shin, H.C.; Cho, J.Y.; Kang, S.K.; Lee, H.J.; Shin, S.C.; Park, K.H.; Moon, J.H. Isolation and structural determination of free radical scavenging compounds from Korean fermented red pepper past (kochujang). Food Sci. Biotechnol. 2009, 18, 463-470.
53. Wang, X.Y.; Xu, M.; Yang, C.R.; Zhang, Y.J. Phenylpropanoid glycosides from the seeds of Michelia hedyosperma. Food Chem. 2011, 126, 1039-1043. [CrossRef]
54. Simaratanamongkol, A.; Umehara, K.; Noguchi, H.; Panichayupakaranant, P. Identification of a new angiotensin-converting enzyme (ACE) inhibitor from Thai edible plants. Food Chem. 2014, 165, 92-97. [CrossRef] [PubMed]
55. Guerrero, L.; Castillo, J.; Quiñones, M.; Garcia-Vallvé, S.; Arola, L.; Pujadas, G.; Muguerza, B. Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies. PLoS ONE 2012, 7, e49493. [CrossRef] [PubMed]
56. Balasuriya, B.W.N.; Rupasinghe, H.P.V. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Funct. Foods Health Dis. 2011, 5, 172-188.
57. Actis-Goretta, L.; Ottaviani, J.I.; Fraga, C.G. Inhibition of angiotensin converting enzyme activity by flavonol-rich foods. J. Agric. Food Chem. 2006, 11, 229-234. [CrossRef] [PubMed]
58. Kakkar, S.; Bais, S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol. 2014. [CrossRef] [PubMed]
59. Seifried, H.E.; Anderson, D.E.; Fisher, E.I.; Milner, J.A. A review of the interaction among dietary antioxidants and reactive oxygen species. J. Nutr. Biochem. 2007, 11, 567-579. [CrossRef] [PubMed]
60. Gonzáleza, R.; Ballesterc, I.; López-Posadasa, R.; Suárezb, M.D.; Martínez-Augustinb, O.; Zarzuelob, A.; Sánchez de Medinaa, F. Effects of flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci. Nutr. 2011, 51, 331-362. [CrossRef] [PubMed]
61. Cushman, D.W.; Cheung, H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20, 1637-1648. [CrossRef]
62. Moshage, H.; Kok, B.; Huizenga, J.R.; Jansen, P.L.M. Nitrite and Nitrate determinations in plasma: A critical evaluation. Chin. Chem. 1995, 41, 892-896.
63. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254. [CrossRef]
64. Ledwozyw, A.; Michalak, J.; Stepian, A.; Kadziolka, A. The relationship between plasma TG, cholesterol, total lipid peroxidation product during human atherosclerosis. Clin. Chim. Acta 1986, 155, 272-284.
65. Reznick, A.Z.; Packer, L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Meth. Enzymol. 1994, 233, 357-363. [PubMed]
66. Rahman, I.; Kode, A.; Biswas, S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 2006, 1, 3159-3165. [CrossRef] [PubMed]